Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank79
3Y CAGR+18.4%
5Y CAGR+6.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+18.4%/yr
vs -24.8%/yr prior
5Y CAGR
+6.0%/yr
Recent acceleration
Acceleration
+43.1pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $40.58M | -28.5% |
| 2024 | $56.75M | +73.1% |
| 2023 | $32.79M | +34.0% |
| 2022 | $24.46M | +29.5% |
| 2021 | $18.89M | -37.8% |
| 2020 | $30.37M | +34.9% |
| 2019 | $22.52M | -70.5% |
| 2018 | $76.32M | +99.3% |
| 2017 | $38.29M | +117.2% |
| 2016 | $17.63M | - |